Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) - Total Liabilities

Latest as of March 2026: CN¥640.98 Million CNY ≈ $93.79 Million USD

Based on the latest financial reports, Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) has total liabilities worth CN¥640.98 Million CNY (≈ $93.79 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 600613 net assets growth trend to track the company's year-over-year net asset growth rate.

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A - Total Liabilities Trend (1992–2025)

This chart illustrates how Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A's total liabilities have evolved over time, based on quarterly financial data. See Shanghai Shenqi Pharmaceutical Investmen free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A Competitors by Total Liabilities

The table below lists competitors of Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A ranked by their total liabilities.

Company	Country	Total Liabilities
Contango ORE Inc NYSE MKT:CTGO	USA	$169.85 Million
DongGuan Winnerway Industrial Zone Ltd SHE:000573	China	CN¥455.75 Million
Taiwan Mask Corp TW:2338	Taiwan	NT$13.60 Billion
Zhejiang Xinchai Co. Ltd. SHE:301032	China	CN¥1.69 Billion
Evolent Health Inc NYSE:EVH	USA	$1.48 Billion
Dimerco Express TWO:5609	Taiwan	NT$3.60 Billion
Oxiquim S.A SN:OXIQUIM	Chile	CL$118.48 Billion
Meshflow Acquisition Corp. Class A Ordinary Shares NASDAQ:MESH	USA	$14.86 Million

Liability Composition Analysis (1992–2025)

This chart breaks down Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Shanghai Shenqi Pharmaceutical Investmen.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.61	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.28	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.21	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (1992–2025)

The table below shows the annual total liabilities of Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A from 1992 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥747.59 Million ≈ $109.40 Million	+8.50%
2024-12-31	CN¥689.01 Million ≈ $100.82 Million	-22.48%
2023-12-31	CN¥888.77 Million ≈ $130.05 Million	-11.82%
2022-12-31	CN¥1.01 Billion ≈ $147.49 Million	+33.24%
2021-12-31	CN¥756.45 Million ≈ $110.69 Million	-1.79%
2020-12-31	CN¥770.28 Million ≈ $112.72 Million	-13.90%
2019-12-31	CN¥894.60 Million ≈ $130.91 Million	+69.51%
2018-12-31	CN¥527.74 Million ≈ $77.23 Million	-6.65%
2017-12-31	CN¥565.34 Million ≈ $82.73 Million	-0.39%
2016-12-31	CN¥567.56 Million ≈ $83.05 Million	+47.43%
2015-12-31	CN¥384.98 Million ≈ $56.33 Million	+50.62%
2014-12-31	CN¥255.60 Million ≈ $37.40 Million	+39.35%
2013-12-31	CN¥183.42 Million ≈ $26.84 Million	+654.66%
2012-12-31	CN¥24.31 Million ≈ $3.56 Million	-23.02%
2011-12-31	CN¥31.57 Million ≈ $4.62 Million	+10.85%
2010-12-31	CN¥28.48 Million ≈ $4.17 Million	-53.01%
2009-12-31	CN¥60.61 Million ≈ $8.87 Million	+14.26%
2008-12-31	CN¥53.04 Million ≈ $7.76 Million	-41.21%
2007-12-31	CN¥90.23 Million ≈ $13.20 Million	-14.22%
2006-12-31	CN¥105.19 Million ≈ $15.39 Million	-4.09%
2005-12-31	CN¥109.67 Million ≈ $16.05 Million	-40.71%
2004-12-31	CN¥184.98 Million ≈ $27.07 Million	+32.17%
2003-12-31	CN¥139.96 Million ≈ $20.48 Million	-2.39%
2002-12-31	CN¥143.38 Million ≈ $20.98 Million	-8.76%
2001-12-31	CN¥157.14 Million ≈ $22.99 Million	-7.00%
2000-12-31	CN¥168.97 Million ≈ $24.73 Million	+13.06%
1999-12-31	CN¥149.46 Million ≈ $21.87 Million	-61.11%
1998-12-31	CN¥384.28 Million ≈ $56.23 Million	+80.69%
1997-12-31	CN¥212.67 Million ≈ $31.12 Million	+26.19%
1996-12-31	CN¥168.53 Million ≈ $24.66 Million	-0.56%
1995-12-31	CN¥169.48 Million ≈ $24.80 Million	+7.14%
1994-12-31	CN¥158.19 Million ≈ $23.15 Million	+51.64%
1993-12-31	CN¥104.32 Million ≈ $15.27 Million	+23.97%
1992-12-31	CN¥84.15 Million ≈ $12.31 Million	--

About Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A

SHG:600613 China Drug Manufacturers - General

Market Cap

$346.49 Million

CN¥2.37 Billion CNY

Market Cap Rank

#14107 Global

#4194 in China

Share Price

CN¥4.94

Change (1 day)

-1.59%

52-Week Range

CN¥4.44 - CN¥7.19

All Time High

CN¥24.35